In an interview with Barron’s, GMP Securities analyst Rob Fagan says he’s more bullish on U.S. pot stocks than their Canadian counterparts.
- U.S. Stocks he likes include Curaleaf, Cresco Labs, Harvest Health and Recreation, Trulieve and Green Thumb Industries.
- Fagan: “The markets where these companies operate are fantastic. Massachusetts converted from medical to recreational sales and is growing above a 500% annualized clip right now. Even a mature market like Arizona is still growing at a better than 30% annual rate.”